These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
981 related articles for article (PubMed ID: 33996408)
1. Biological drug and drug delivery-mediated immunotherapy. Xiao Q; Li X; Li Y; Wu Z; Xu C; Chen Z; He W Acta Pharm Sin B; 2021 Apr; 11(4):941-960. PubMed ID: 33996408 [TBL] [Abstract][Full Text] [Related]
2. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment. Yang M; Li J; Gu P; Fan X Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371 [TBL] [Abstract][Full Text] [Related]
3. Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways. Futosi K; Fodor S; Mócsai A Int Immunopharmacol; 2013 Dec; 17(4):1185-97. PubMed ID: 24263067 [TBL] [Abstract][Full Text] [Related]
4. Emerging role of natural products in cancer immunotherapy. Dong S; Guo X; Han F; He Z; Wang Y Acta Pharm Sin B; 2022 Mar; 12(3):1163-1185. PubMed ID: 35530162 [TBL] [Abstract][Full Text] [Related]
5. Neutrophil cell surface receptors and their intracellular signal transduction pathways. Futosi K; Fodor S; Mócsai A Int Immunopharmacol; 2013 Nov; 17(3):638-50. PubMed ID: 23994464 [TBL] [Abstract][Full Text] [Related]
6. Advanced application of stimuli-responsive drug delivery system for inflammatory arthritis treatment. Zhang M; Hu W; Cai C; Wu Y; Li J; Dong S Mater Today Bio; 2022 Mar; 14():100223. PubMed ID: 35243298 [TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stromal cells for bone sarcoma treatment: Roadmap to clinical practice. Stamatopoulos A; Stamatopoulos T; Gamie Z; Kenanidis E; Ribeiro RDC; Rankin KS; Gerrand C; Dalgarno K; Tsiridis E J Bone Oncol; 2019 Jun; 16():100231. PubMed ID: 30956944 [TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns. Chatterton DE; Nguyen DN; Bering SB; Sangild PT Int J Biochem Cell Biol; 2013 Aug; 45(8):1730-47. PubMed ID: 23660296 [TBL] [Abstract][Full Text] [Related]
15. Chimeric antigen receptor engineering: a right step in the evolution of adoptive cellular immunotherapy. Figueroa JA; Reidy A; Mirandola L; Trotter K; Suvorava N; Figueroa A; Konala V; Aulakh A; Littlefield L; Grizzi F; Rahman RL; Jenkins MR; Musgrove B; Radhi S; D'Cunha N; D'Cunha LN; Hermonat PL; Cobos E; Chiriva-Internati M Int Rev Immunol; 2015 Mar; 34(2):154-87. PubMed ID: 25901860 [TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Lee BC; Lee J Biochim Biophys Acta; 2014 Mar; 1842(3):446-62. PubMed ID: 23707515 [TBL] [Abstract][Full Text] [Related]
17. Emerging views of mitophagy in immunity and autoimmune diseases. Xu Y; Shen J; Ran Z Autophagy; 2020 Jan; 16(1):3-17. PubMed ID: 30951392 [TBL] [Abstract][Full Text] [Related]
18. Pulmonary delivery of siRNA against acute lung injury/acute respiratory distress syndrome. Zoulikha M; Xiao Q; Boafo GF; Sallam MA; Chen Z; He W Acta Pharm Sin B; 2022 Feb; 12(2):600-620. PubMed ID: 34401226 [TBL] [Abstract][Full Text] [Related]
19. SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases. Larionova R; Byvaltsev K; Kravtsova О; Takha E; Petrov S; Kazarian G; Valeeva A; Shuralev E; Mukminov M; Renaudineau Y; Arleevskaya M J Transl Autoimmun; 2022; 5():100154. PubMed ID: 35434592 [TBL] [Abstract][Full Text] [Related]
20. NINJ1: A new player in multiple sclerosis pathogenesis and potential therapeutic target. Xu Y; Zhang E; Wei L; Dai Z; Chen S; Zhou S; Huang Y Int Immunopharmacol; 2024 Nov; 141():113021. PubMed ID: 39197295 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]